Atika Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Atika Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-27,500	Closed	-$1.27M	–	75
2016 Q3	$1.27M	Sell	27,500 -1,500	-5%	-$84.6K	0.52%	59
2016 Q2	$1.48M	Buy	+29,000	New	+$1.44M	0.63%	48
2016 Q1	–	Sell	-58,000	Closed	-$4.55M	–	66
2015 Q4	$4.55M	Buy	+58,000	New	+$3.35M	2.34%	16
2015 Q2	–	Sell	-9,000	Closed	-$419K	–	79
2015 Q1	$419K	Buy	+9,000	New	+$467K	0.28%	60
2014 Q3	–	Sell	-8,500	Closed	-$360K	–	79
2014 Q2	$360K	Buy	+8,500	New	+$312K	0.29%	58

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atika Capital Management's ISEE Position: Q4 2016 in Review

Atika Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 27,500 shares — an estimated $1.27M sold.

Atika Capital Management first reported a position in ISEE in Q2 2014 and held it in 5 quarters. The position peaked at $4.55M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

Atika Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Atika Capital Management sold 27,500 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $1.27M.
Atika Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
Atika Capital Management's IVERIC bio, Inc. Common Stock position peaked at $4.55M in Q4 2015.
137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Atika Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.